Clinical laboratories strive to enhance productivity, efficiency, and regulatory compliance. Industry Lab Diagnostic Partners (ILDP) recently completed a technical assessment for molecular testing of SARS-COV-2, Flu A, Flu B, and RSV, ensuring their multiplex assay workflow meets regulatory standards. Troy Evans, ILDP Founder, will discuss the decision-making process and regulatory navigation involved in implementing this workflow, demonstrating its reliability for accurate patient testing.
